---
layout: post
published: FALSE
title: What's new for 'fibromyalgia' in PubMed - valproate analgesic effect, obesity,
  and more!
date: '2011-10-15T11:32:00.000-03:00'
author: Francisco H C Felix
tags:
- Fibromyalgia
lang: en-us
ref:
modified_time: '2011-10-15T11:32:23.730-03:00'
blogger_id: tag:blogger.com,1999:blog-2993346515708552092.post-3820863323523266577
blogger_orig_url: https://pharmak.blogspot.com/2011/10/whats-new-for-fibromyalgia-in-pubmed.html
---

This message contains My NCBI what's new results from the National Center for Biotechnology <br /><b>Sender's message: </b>Search: fibromyalgia <br />Sent on Saturday, 2011 Oct 08<br />Search <b>fibromyalgia</b> <br /><div><br /><div><table bgcolor="#CCCCCC"><tbody><tr><td align="center">PubMed Results</td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">1.</td><td valign="top"><a href="https://www.ncbi.nlm.nih.gov/pubmed/21975791" ref="ordinalpos=2">Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Gill D,  Derry S,  Wiffen PJ,  Moore RA.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="Cochrane database of systematic reviews (Online)">Cochrane Database Syst Rev</span>. 2011 Oct 5;10:CD009183.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21975791 [PubMed - in process]<br /><br /><b>This large meta-analysis shows how little we know about the analgesic use of valproate, or valproic acid. </b><br /></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">2.</td><td valign="top"><a href="https://www.ncbi.nlm.nih.gov/pubmed/21972124" ref="ordinalpos=6">The association of body mass index with symptom severity and quality of life in patients with fibromyalgia.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Kim CH,  Luedtke CA,  Vincent A,  Thompson JM,  Oh TH.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="Arthritis care &amp; research">Arthritis Care Res (Hoboken)</span>. 2011 Oct 3. doi: 10.1002/acr.20653. [Epub ahead of print]</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21972124 [PubMed - as supplied by publisher]<br /><br /><b>Does overweight and obesity have any relation with pain severity in fibromyalgia? Read this article and find out!</b> <i>(tip: yes, obesity has a relation with pain in these patients)</i><br /></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">3.</td><td valign="top"><a href="https://www.ncbi.nlm.nih.gov/pubmed/21970699" ref="ordinalpos=7">Clinical comorbidities,  treatment patterns,  and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Gore M,  Tai KS,  Chandran A,  Zlateva G,  Leslie D.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="Journal of medical economics">J Med Econ</span>. 2011 Oct 4. [Epub ahead of print]</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21970699 [PubMed - as supplied by publisher]<br /><br /><b>FDA-approved drugs for fibromyalgia did not diminish multiple drug using and high health care costs in usual care setings: are we right in indicating these drugs for fibro patients?</b></td></tr></tbody></table></div></div>
